Skip to contentGILLIS STEVEN — CORIXA CORP insider: 170 transactions · InsiderLensGILLIS STEVEN
- 10% owner at Neumora Therapeutics, Inc. · on record since Sep 29, 2023
- 10% owner at BOLD ENERGY INC. · on record since Mar 27, 2024
- 10% owner at Rapport Therapeutics, Inc. · on record since Jun 10, 2024
- 10% owner at Maze Therapeutics, Inc. · on record since Jan 30, 2025
- 10% owner at Metsera, Inc. · on record since Jan 30, 2025
- 10% owner at Lyell Immunopharma, Inc. · on record since Jul 29, 2025
- Director at Metsera, Inc. · on record since Nov 14, 2025
- Director at TAKEDA PHARMACEUTICAL CO LTD · on record since Mar 18, 2026
- 10% owner at Kardigan, Inc. · on record since Jun 18, 2026
- Director at Trubion Pharmaceuticals, Inc · on record since Nov 17, 2009
- 10% owner at Verve Therapeutics, Inc. · on record since Jun 23, 2021
- 10% owner at Seaport Therapeutics, Inc. · on record since Apr 30, 2026
- Director at CORIXA CORP · on record since Dec 18, 2003
- CEO at CORIXA CORP · on record since Dec 18, 2003
- Director at BLUE HOLDINGS, INC. · on record since Jun 26, 2013
- Director at PAULSON CAPITAL CORP · on record since Aug 4, 2014
- 10% owner at PAULSON CAPITAL CORP · on record since Aug 4, 2014
- Director at Ruthigen, Inc. · on record since Jun 25, 2015
- Director at PHASERX, INC. · on record since May 25, 2016
- 10% owner at PHASERX, INC. · on record since May 25, 2016
- Director at Q32 Bio Inc. · on record since Mar 29, 2018
- 10% owner at Sienna Biopharmaceuticals, Inc. · on record since Feb 26, 2019
- Director at Codiak BioSciences, Inc. · on record since Oct 20, 2020
- 10% owner at Sana Biotechnology, Inc. · on record since Feb 10, 2021
- 10% owner at DA32 Life Science Tech Acquisition Corp. · on record since Jul 27, 2021
- 10% owner at Erasca, Inc. · on record since Jul 20, 2021
- 10% owner at Prime Medicine, Inc. · on record since Oct 26, 2022
- Director at Kardigan, Inc. · on record since Jun 24, 2026
Insider trading activity of GILLIS STEVEN
- Transactions on record
- 170
- since Dec 18, 2003
- Open-market buys
- 14
- $69.6M
- Open-market sells
- 7
- $9.3M
- Companies traded
- 12
- last filing Aug 1, 2025
Figures computed from official regulatory filings — methodology.
Companies where GILLIS STEVEN has traded
- TAKEDA PHARMACEUTICAL CO LTD2 tx · Jul 6, 2026
- Prime Medicine, Inc.1 tx · $10M · Aug 1, 2025
- Metsera, Inc.9 tx · $40M · Feb 3, 2025
- BOLD ENERGY INC.12 tx · $3.2M · Apr 4, 2024
- PAULSON CAPITAL CORP20 tx · $8.3M · Jul 28, 2023
- Q32 Bio Inc.9 tx · Jun 15, 2023
- Codiak BioSciences, Inc.14 tx · $3.5M · Feb 21, 2023
- Ruthigen, Inc.23 tx · Sep 1, 2020
- Sienna Biopharmaceuticals, Inc.3 tx · $5.4M · Feb 26, 2019
- PHASERX, INC.
Track record of GILLIS STEVEN
Statistical track record
Free- Open-market buys
- 16
- Last buy
- Aug 1, 2025
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of GILLIS STEVEN
Co-insiders of GILLIS STEVEN
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
2 tx · May 30, 2017
ARCH Venture Fund X, L.P.Erasca, Inc. +5
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jul 6, 2026 | Award | 3,800 | 0.00 USD | — | SEC |
| Jul 6, 2026 | AwardD | 1,319 | 0.00 USD | — | SEC |
| Aug 1, 2025 | Buy | 3,030,300 | 3.30 USD | $10M | SEC |
| Feb 3, 2025 | OtherD | -15,000,000 | — | — | SEC |
| Feb 3, 2025 | OtherD | -19,933,333 | — | — | SEC |
| Feb 3, 2025 | OtherD | -15,000,000 | — | — | SEC |
| Feb 3, 2025 | Buy | 1,432,224 | 18.00 USD | $25.8M | SEC |
| Feb 3, 2025 | Buy | 789,998 | 18.00 USD | $14.2M | SEC |
| Feb 3, 2025 | OtherD | -2,678,571 | — | — | SEC |
| Feb 3, 2025 | OtherD | -2,678,571 | — | — | SEC |
| Feb 3, 2025 | Other | 7,523,682 | — | — | SEC |
| Feb 3, 2025 | Other | 16,006,949 | — | — | SEC |
| Apr 4, 2024 | OtherD | -164,835 | — | — | SEC |
| Apr 4, 2024 | OtherD | -227,920 | — | — | SEC |
| Apr 4, 2024 | OtherD | -201,465 | — | — | SEC |
| Apr 4, 2024 | Other | 589,743 | — | — | SEC |
| Apr 4, 2024 | Buy | 133,333 | 16.00 USD | $2.1M | SEC |
| Apr 4, 2024 | OtherD | -454,212 | — | — | SEC |
| Apr 4, 2024 | Buy | 66,667 | 16.00 USD | $1.1M | SEC |
| Apr 4, 2024 | OtherD | -424,908 | — | — | SEC |
| Apr 4, 2024 | Other | 1,048,433 | — | — | SEC |
| Apr 4, 2024 | Other | 787,545 | — | — | SEC |
| Apr 4, 2024 | OtherD | -366,301 | — | — | SEC |
| Apr 4, 2024 | OtherD | -586,080 | — | — | SEC |
| Jul 28, 2023 | AwardD | 52,500 | 0.00 USD | $0 | SEC |